Real-World Effectiveness of First-Line Osimertinib Versus Amivantamab-Based Regimens in EGFR-Mutated NSCLC: A Multicenter Comparative Outcome Study
Crossref DOI link: https://doi.org/10.18081/ajbm.2025.4.330
Published Online: 2025-12-30
Update policy: https://doi.org/10.18081/ajbm/2025.0/001
Thompson, Emily R.
Carter, Daniel J.
Rahman, Aisha M.
